Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank50
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-231000.00
↑ 20% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-289000.00
Historical baseline
PeriodValueYoY Change
TTM$-231000.00+55.1%
2024$-514000.00-24.2%
2023$-414000.00-250.8%
2022$-118000.00+29.8%
2021$-168000.00-